SBA (REINTERPRETATION telemedine call to check progress of Treatment)
This is a short telemedicine follow-up consult done by a board-certified MD or Dr. Joseph Zelk and other board-certified sleep medicine MDs. This is an interpretation of the progress you have made after titration of treatment on moderate to severe sleep apnea patients. You should have sent in a final endpoint HST so that this consult can evaluate the progress and see if a new direction or added treatment is needed. This consult is often needed to continue CPAP or oral appliance therapy for insurance benefits to be approved or not.
This is a short telemedicine follow-up consult done by a board-certified MD or Dr. Joseph Zelk and other board-certified sleep medicine MDs. This is an interpretation of the progress you have made after titration of treatment on moderate to severe sleep apnea patients. You should have sent in a final endpoint HST so that this consult can evaluate the progress and see if a new direction or added treatment is needed. This consult is often needed to continue CPAP or oral appliance therapy for insurance benefits to be approved or not.
This is a short telemedicine follow-up consult done by a board-certified MD or Dr. Joseph Zelk and other board-certified sleep medicine MDs. This is an interpretation of the progress you have made after titration of treatment on moderate to severe sleep apnea patients. You should have sent in a final endpoint HST so that this consult can evaluate the progress and see if a new direction or added treatment is needed. This consult is often needed to continue CPAP or oral appliance therapy for insurance benefits to be approved or not.
Joseph Zelk, DNP, FNP, BC, CBSM, DBSM
Dr. Zelk is a board certified sleep specialist. He is passionate about furthering the implementation of home sleep diagnostics, home CPAP titration and training medical and dental clinicians in mandibular advancement therapy. Dr. Zelk has championed the use of combination therapies to overcome the dependance on CPAP treatment and optimize the outcomes of obstructive sleep apnea solutions.
He is actively working in developing new patents and FDA approved devices in the area of OSAS treatments.